Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» immunotherapy
immunotherapy
Not just cancer: Seattle biotechs, researchers explore immunotherapy for other diseases
Bizjournals.com
Fri, 08/28/15 - 07:59 am
Seattle
cancer
immunotherapy
Juno Therapeutics
Ichor, J&J to collaborate in $85M hep B immunotherapy deal
BioPharma Dive
Wed, 04/15/15 - 08:51 am
Ichor
JNJ
hepatitis B
immunotherapy
TapImmune's CEO Says Company Is Preparing "A Very Deep Pipeline in Multiple Indications" for Phase II Trials
Yahoo
Tue, 02/10/15 - 10:04 am
TapImmune
immunotherapy
Lilly to Pair With Merck, Bristol on Cancer Drug Trials
WSJ Online
Tue, 01/13/15 - 09:54 am
Eli Lilly
Merck
Bristol-Myers Squibb
immunotherapy
clinical trials
2015 an "important year" for Pfizer's IO pipeline, analysts say
Medical Marketing and Media
Fri, 11/14/14 - 10:59 am
Pfizer
immunotherapy
Merck immunotherapy drug shows promise in bladder cancer
Yahoo/Reuters
Mon, 09/29/14 - 07:52 am
Merck
bladder cancer
immunotherapy
Keytruda
Amgen One Step Closer To Immunotherapy Market
Bidness Etc.
Tue, 09/23/14 - 07:33 am
Amgen
immunotherapy
blinatumomab
acute lymphoblastic leukemia
Pharma’s Huge Bet on Immunotherapies
Motley Fool
Wed, 06/25/14 - 07:35 am
immunotherapy
anti-PD-1 immunotherapy
anti-PD-L1
MK-3475
Merck
nivolumab
Roche
Bristol-Myers Squibb
Incyte's 'IDO' Cancer Immunotherapy Causes Investor Scrum at ASCO '14
TheStreet.com
Mon, 06/2/14 - 06:09 pm
Incyte
ASCO
immunotherapy
melanoma
INCB024360
U.S. to test Bristol-Myers immunotherapy drugs on newly diagnosed brain tumors
Yahoo/Reuters
Mon, 06/2/14 - 09:42 am
Yervoy
brain cancer
immunotherapy
Bristol-Myers Squibb
ASCO
nivolumab
Bristol-Myers racing to the FDA with immunotherapy star nivolumab
Fierce Biotech
Tue, 04/29/14 - 10:05 am
FDA
immunotherapy
nivolumab
Bristol-Myers Squibb
Who's going to win pharma's immunotherapy gold rush?
Fierce Biotech
Tue, 03/25/14 - 08:08 am
immunotherapy
Roche
Bristol-Myers Squibb
Merck
PDL-1
anti-PD-1 immunotherapy
melanoma
3 Growing Immunotherapy Companies: Celldex, Merck, OncoSec
Wall St Cheat Sheet
Mon, 02/10/14 - 11:28 am
immunotherapy
Celldex
Merck
OncoSec
Ablynx agrees Merck cancer deal worth up to 1.7 billion euros
Yahoo/Reuters
Mon, 02/3/14 - 08:50 am
Ablynx
Merck
immunotherapy
6 Reasons Why Bristol-Myers Is A Good Immuno-Oncology Investment For 2014
Seeking Alpha
Fri, 01/31/14 - 08:14 am
oncology
immunotherapy
Bristol-Myers Squibb
melanoma
Yervoy
Advaxis And Inovio Race For First Cervical Cancer Immunotherapy
Seeking Alpha
Thu, 01/23/14 - 09:48 am
Advaxis
Inovio
cervical cancer
immunotherapy
ADXS-HPV
VGX-3100
Amazon's Jeff Bezos bets some of his personal cash on Juno's immunotherapy tech
Fierce Biotech
Tue, 01/14/14 - 10:00 am
Amazon
Jeff Bezos
Juno Therapeutics
immunotherapy
OncoSec Medical Poised for Exciting 2014
Wall St Cheat Sheet
Mon, 12/30/13 - 11:39 am
OncoSec Medical
melanoma
skin cancer
immunotherapy
Keep an Eye on These 3 Revolutionary Cancer Treatments in 2014
Motley Fool
Fri, 12/27/13 - 01:08 pm
cancer
Roche
Infinity Pharmaceuticals
Inovio
Immunogen
Gilead Sciences
immunotherapy
antibody-drug conjugate
Inovio CEO Interview: PD1/PDL1 Inhibitors, Immunotherapy And Why Investors Should Be Excited About 2014
Seeking Alpha
Fri, 12/20/13 - 11:49 am
Inovio
Pharma CEOs
PDL-1
immunotherapy
Joseph Kim
Bristol-Myers Squibb
Roche
Dendreon
GSK
ImmunoCellular Therapeutics
Merck
Northwest Biotherapeutics
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »